Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

In the most recent trading session, Moderna (MRNA) closed at $25.51, indicating a +2.03% shift from the previous trading day.

Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), has also been particularly outspoken ...

Moderna is producing its first made-in-Canada COVID-19 shots at facilities in Laval, Que. and Cambridge, Ont. The Laval ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

The US Food and Drug Administration (FDA) has approved updated mRNA vaccines from Moderna and Pfizer/BioNTech that protect ...

Researchers warn that halting federal contracts for mRNA vaccine research could weaken pandemic preparedness and slow medical advances.

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its ...

Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was “encouraged” by the company’s dialogue with the ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...